Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 11Unknown 3Withdrawn 2Recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2

Conditions

Multiple Myeloma 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Neoplasms, Plasma Cell 14Recurrence 12Leukemia 12Vomiting 11Lymphoma, Extranodal NK-T-Cell 11Lymphoma 11Neoplasms 9Nausea 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Non-Hodgkin 4Lymphoma, Follicular 4Paraproteinemias 3Lymphoma, T-Cell, Peripheral 3Lymphoma, B-Cell, Marginal Zone 3Lymphohistiocytosis, Hemophagocytic 3Lung Neoplasms 3Immunoglobulin Light-chain Amyloidosis 3Hematologic Diseases 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Burkitt Lymphoma 3Breast Neoplasms 3Blood Protein Disorders 3Renal Insufficiency 2Postoperative Nausea and Vomiting 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2

Interventions

Cyclophosphamide 9Radiotherapy 5Rituximab 4Peripheral Blood Stem Cell Transplantation 4Cyclosporine 4fludarabine phosphate 3Melphalan 3Indium 3Filgrastim 3Dexamethasone 3sargramostim 2epratuzumab 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Metronidazole 2Lym-1 monoclonal antibody 2Lenalidomide 2Interferon-alpha 2Idarubicin 2Etoposide 2Cytarabine 2Clarithromycin 2Cisplatin 2Busulfan 2Antilymphocyte Serum 2Amoxicillin 2motesanib diphosphate 1ledipasvir, sofosbuvir drug combination 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Lymphoma, B-Cell, Marginal Zone × Dexamethasone × Clear all
NCT03335098 2017-11-07

BOMB-THROW

Seoul National University Hospital

Phase 2 Unknown
15 enrolled
Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT00002481 2013-12-18

Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003639 2013-09-17

Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡